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Case Report
Lymphadenitis in a Greenlandic Inuit Boy 
after Bacillus Calmette-Guérin Vaccination
Luit Penninga1, anne Kathrine Lorentzen1 and Carsten sauer 
MiKKeLsen2
1Ilulissat Hospital, Ilulissat, Avannaa Region, Postbox 514, 3952 Ilulissat, 
Greenland, 2Research Lab, Department of Dermatology, University of Aalborg, 
and Private Dermatology Practice, Brønderslev, Denmark. E-mail: LP@ctu.dk
As Greenland has an exceedingly high incidence of tuber-
culosis, the Bacillus Calmette-Guérin (BCG) vaccination is a 
part of the childhood immunization programme (1, 2). Severe 
complications to the BCG vaccination are very rare. One of 
the most well-known complications associated with BCG 
vaccination is lymphadenitis, which can usually be treated 
without sequelae (3). We report here a Greenlandic Inuit 
boy who developed non-suppurative lymphadenitis and was 
treated conservatively with good results.
Case RepoRt
A Greenlandic Inuit boy was born at term after an uncompli-
cated pregnancy and normal vaginal delivery. Intracutaneous 
BCG vaccination was given in the left upper arm. He was 
discharged from the regional hospital and went home to the 
rural village in which the family lived. A few weeks later, the 
mother observed a swelling in the left armpit and contacted 
the hospital. A large swelling in the left axilla was found (Fig. 
1). The swelling was painless, smooth, firm, and not fixed to 
the underlying tissue. There was no erythema or other cuta-
neous changes. The BCG inoculation site was without signs of 
infection (Fig. 2.) The child was thriving and gaining weight 
and did not show any signs of systemic affection. An ultra-
sound of the swelling did not detect any fluid. Neither biopsy 
nor excision was performed. After 3–4 months, the swelling 
decreased in size, and after 6 months it had disappeared. 
DisCussion
In the 1950s, the population of Greenland had the highest 
rate of tuberculosis worldwide (1). Hence, a nationwide neo-
nate vaccination programme with the BCG vaccination was 
introduced in 1955. In 1989, this intervention was phased out 
as tuberculosis was basically extinct in Greenland, and the 
vaccination programme ended in 1991 (1). From 1991 to 1997 
the incidence of tuberculosis doubled and the vaccination 
programme was reinitiated (2). Children born between 1991 
and 1997 were offered vaccination, but many failed to receive 
the offer or did not accept the vaccination (2). Therefore, there 
is a higher incidence of tuberculosis in people born between 
1991 and 1997 compared to the rest of the population, and 
men are more often affected than women (2). 
However, the incidence of tuberculosis in Greenland is de-
clining due to better surveillance, management, and infection 
control. Tuberculosis is still endemic, and the BCG vaccination 
continues to be a part of the immunization programme in 
Greenland (2).
In this case report, we describe a rare complication to the BCG 
vaccination (3). Lymphadenitis occurs in 3/1,000 children 
who receive the vaccination (4). Lymphadenitis often occurs 
at the ipsilateral arm of the vaccination site (5). Normally, 
there are no signs of infection, and the patient has no fever. 
The lymphadenitis is characterized by isolated axillary, su-
Fig. 1. Severe lymphadenitis of the axilla after Bacillus Calmette-Guérin 
vaccination of the ipsilateral arm.
Fig. 2. No signs of infection were seen at the site of Bacillus Cal-
mette-Guérin injection.
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praclavicular or cervical lymph node enlargement (5). The 
primary diagnostic modality is ultrasonography (5). Computed 
tomography can also be used, but is not recommended as it 
exposes the child to radiation (5). 
Two forms of BCG lymphadenitis can occur; simple or 
non-suppurative lymphadenitis, and suppurative lymph-
adenitis. In non-suppurative lymphadenitis, there is no fluid 
collection, and the condition is best treated conservatively. 
Spontaneous regression usually occurs over a period of sev-
eral weeks or months (3). Suppurative BCG lymphadenitis is 
characterized by the development of a fluid collection in the 
swelling, with erythema and oedema of the overlying skin. 
Suppurative lymphadenitis resolves through spontaneous per-
foration and sinus formation, followed by secondary closure of 
the sinus by scar tissue. Suppurative BCG lymphadenitis can 
be treated by aspiration with a needle to accelerate resolution 
and prevent spontaneous perforation and sinus formation. 
Surgical excision is rare and should only be applied in cases 
where needle aspiration has failed.
In our patient, ultrasonography showed no fluid collection, 
and this case of non-suppurative lymphadenitis was treated 
conservatively with good results.
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